The pharmaceutical industry is a "market for lemons," a market in which the seller knows much more than the buyer about the product and can profit from selling products less effective and less safe than consumers are led ...
Aug 17, 2010
5 / 5 (4)
0
Gene therapy for a severe inherited blindness, which produced dramatic improvements last year in 12 children and young adults who received the treatment in a clinical trial, has cleared another hurdle. The ...
Mar 03, 2010
not rated yet
0
TGen Drug Development (TD2) and Critical Outcome Technologies Inc. (COTI) announced today that they will work together to obtain approval of clinical trials for a promising new anti-cancer drug called COTI-2.
Jan 12, 2010
not rated yet
0
Females can be too attractive to the opposite sex -- too attractive for their own good -- say biologists at UC Santa Barbara. They found that, among fruit flies, too much male attention directed toward attractive ...
Dec 08, 2009
4 / 5 (5)
0
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat ...
Nov 05, 2009
3 / 5 (1)
0
By discovering the atomic structure of a key human enzyme, researchers at The University of Texas at Austin have pointed the way toward designing anti-HIV drugs with far less toxic side effects.
Oct 15, 2009
not rated yet
0
Every year, 42,000 Americans are diagnosed with pancreatic cancer. Few live very long, and less than 5% are still alive five years after diagnosis.
Jul 20, 2009
not rated yet
1
A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease.
Jul 06, 2009
3.7 / 5 (3)
0
Small synthetic fragments of genetic material called small interfering RNA (siRNA) can block production of abnormal proteins; however, these exciting new drug candidates can also induce a strong immune response, causing toxic ...
May 20, 2009
4 / 5 (1)
0
